Anterior Cruciate Ligament Reconstruction With and Without Lateral Extra-Articular Tenodesis Among High Demand Patients

July 25, 2023 updated by: Ain Shams University

of Anterior Cruciate Ligament Reconstruction With and Without Lateral Extra-Articular Tenodesis Between High Demand Patients: Randomized Controlled Trial

Anterior Cruciate Ligament Reconstruction with and without Lateral Extra-Articular Tenodesis between high demand patients

Study Overview

Detailed Description

It is a randomized control trial comparing between isolated anterior cruciate ligament reconstruction with and without lateral extra articular tenodesis between high demand and high risk groups with high pivot regarding failure rate (primary out come) and patient reported functions score (IKDC and Lysholm)

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Abbasia
      • Cairo, Abbasia, Egypt, 11539
        • Ahmed Abdel Salam Abdel Halim

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • High demand patients (manual workers, athletes,...etc.).
  • Normal average body mass index ( 18.5 - 24.9 ).
  • Age <40 years old.
  • Patients will be diagnosed as ACL tear by the following:

    1. History of knee traumatic event.
    2. Clinical examination ( positive Lachman test and pivot shift test).
    3. Radiological evidence of ACL tear by MRI.
  • patient with high pivot shift test.

Exclusion Criteria:

  • Generalized ligamentous laxity.
  • Other intra or extra articular knee injuries.
  • Previous ACL surgery on the affected knee.
  • Bilateral ACL injuries.
  • Significant Articular surface injury.
  • Medical comorbidities
  • Patients with malalignment ( genu varum, genu valgum or genu recurvatum )
  • Neuromuscular disorders
  • Knee arthritic changes.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Isolated anterior cruciate ligament recnostruction with lateral extra articular tenodesis
Arthroscopic anatomical single bundle anterior cruciate ligament reconstruction with modified Lemiere technique for extra-articular tenodesis
Anatomical single bundle ACLR with modified Lemiere technique
Active Comparator: Isolated anterior cruciate ligament recnostruction without lateral extra articular tenodesis
Arthroscopic anatomical single bundle anterior cruciate ligament reconstruction only
arthroscopic anatomical single bundle ACL Reconstruction

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
failure rate
Time Frame: one year follow up
retear of ACL graft confirmed by clinical examination and MRI
one year follow up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
International knee documentation committee score (IKDC)
Time Frame: at 3,6,9,12 months
The IKDC is a patient-completed tool, which contains sections on knee symptoms (7 items), function (2 items), and sports activities (2 items). Scores range from 0 points (lowest level of function or highest level of symptoms) to 100 points (highest level of function and lowest level of symptoms)
at 3,6,9,12 months
Lysholm score
Time Frame: at 3,6,9,12 months
The Lysholm Knee Score calculates and grades an overall score from 0 to 100 based on 8 domains: squatting, locking, pain, stair climbing, support, instability, and edema. Physicians use this condition-specific, subjective outcome score to assess patient progress after surgery or injury to the knee. Scores range from 0 points (lowest level of function or highest level of symptoms) to 100 points (highest level of function and lowest level of symptoms)
at 3,6,9,12 months
antero-posterior instability measure
Time Frame: at 3,6,9 and 12 months
measure AP instability by KT1000 lachmeter for injured and non injured knee
at 3,6,9 and 12 months
side to side KT 1000 lachmeter difference
Time Frame: one year follow up
measure side to side KT 1000 lachmeter difference by (injured - noninjured)
one year follow up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Amr Mo Abdelhady, Professor, Faculty of medecine, Ain shams university
  • Study Director: Mohamed Ha Sobhey, Professor, Faculty of medecine, Ain shams university
  • Study Director: Moustapha Al ElAbd, lecturer, Faculty of medecine, Ain shams university
  • Study Director: Yehia Mo Haroun, Lecturer, Faculty of medecine, Ain shams university
  • Principal Investigator: Ahmed Ab Amer, Msc, Faculty of medecine, Ain shams university

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 15, 2021

Primary Completion (Actual)

February 15, 2022

Study Completion (Actual)

March 1, 2023

Study Registration Dates

First Submitted

July 6, 2023

First Submitted That Met QC Criteria

July 25, 2023

First Posted (Actual)

July 27, 2023

Study Record Updates

Last Update Posted (Actual)

July 27, 2023

Last Update Submitted That Met QC Criteria

July 25, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anterior Cruciate Ligament Tear

Clinical Trials on Isolated anterior cruciate ligament reconstruction with lateral extra articular tenodesis

Subscribe